Hep C Discussion Forum

Members Login
Username 
 
Password 
    Remember Me  
Chatbox
Please log in to join the chat!
Hep C Discussion Forum -> Hep C News -> FDA plans to rescind Merck's MK5172 + 8742 breakthrough designation
Post Info TOPIC: FDA plans to rescind Merck's MK5172 + 8742 breakthrough designation
suziq


Senior Member

Status: Offline
Posts: 327
Date:
FDA plans to rescind Merck's MK5172 + 8742 breakthrough designation
Permalink  
 

Merck's SVR rates were great !!!  Not thrilled to see that FDA has taken a position to slow down competition against Gilead and AbbVie. 

Of course, I am prejudiced for Merck as I did their clinical trial and got paid to do it.  Considering my age and cirrhosis, Gilead turned me down for their clinical trials. 

I am very grateful to Merck for accepting me and for my SVR.

Hi Zlikster--not sure where Merck will be doing their approaching/current clinical trials.  Good to hear from you.



-- Edited by suziq on Monday 9th of March 2015 07:05:23 AM

__________________

Geno 1A  Age 82 Treatment naive Cirrhotic Told I had liver disease in 1966. Diagnosed as Hep C 1999.Started Merck clinical trial with Riba on 9/9/2013 Week 1 and 2 <25  Weeks 4, 8, 12,16,18 UND.  EOT Jan 14,2014  EOT +12 UND   JULY 1 2014 EOT+24= SVR
Zlikster


Guru

Status: Offline
Posts: 791
Date:
Permalink  
 

Yup, i am keeping my eyes wide open on Merck's clinical trials ;)

Not that much keen on Abbvie's combos with Ritonavir...

__________________

GT 3 dg. 08-2012 / FibroScan: 5 kPa F1 / FibroTest: F0-1 A1 / SoC TX: PegInt 120mcg+Riba 1000mg UND from w8 relapse EOT+4w
01-2016 Sof+Dac+Riba UND from w8, SVR24!
Tig


Admin

Status: Offline
Posts: 9270
Date:
Permalink  
 

The FDA intends to rescind the breakthrough designation of Merck's new investigational drugs. It does state their purchase of Idenix Pharmaceuticals and their plan to ramp up investigational studies later this year.This may be an excellent chance for all interested. Keep your eye open for trial opportunities and we will too.

"We do not see this affecting the development of the combo," said JPMorgan analyst Chris Schott, referring to the potential loss of the special "breakthrough" designation, which provides a gloss of specialness to drugs and can speed up an FDA review.

http://hepatitiscnewdrugs.blogspot.com/2015/02/hepatitis-c-merck-said-fda-intends-to.html#links

Tig



__________________

Tig

67yo GT1A - 5 Mil - A2/F3 - (1996) Intron A - Non Responder, (2013) Peg/Riba/Vic SOT:05/23/13 EOT:12/04/13 SVR 9+ years!

Hep C FAQ   Lab Ref. Ranges  HCV Resistance

Signature Line Set Up/Abbreviations   Payment Assistance

 
Page 1 of 1  sorted by
 
Quick Reply

Please log in to post quick replies.
Hep C Discussion Forum -> Hep C News -> FDA plans to rescind Merck's MK5172 + 8742 breakthrough designation
Legal Disclaimer:

THIS FORUM, IT'S OWNERS, ADMINISTRATORS, MODERATORS AND MEMBERS DO NOT AT ANY TIME GIVE MEDICAL ADVICE AND IN ALL CASES REFER ANYONE HERE TO SEEK APPROPRIATE MEDICAL ADVICE FROM THEIR DOCTOR.